| Primary |
| Atrial Fibrillation |
66.7% |
| Dementia |
33.3% |
|
|
| Secondary |
| Hypertension |
14.5% |
| Thrombosis Prophylaxis |
10.8% |
| Drug Use For Unknown Indication |
6.6% |
| Sleep Disorder |
6.5% |
| Chronic Obstructive Pulmonary Disease |
6.1% |
| Epilepsy |
5.3% |
| Dermatitis |
5.2% |
| Supraventricular Tachycardia |
4.9% |
| Grand Mal Convulsion |
4.8% |
| Nausea |
3.8% |
| Cardiac Failure |
3.6% |
| Hypokalaemia |
3.6% |
| Pruritus |
3.6% |
| Tachycardia Paroxysmal |
3.6% |
| Diabetes Mellitus |
3.0% |
| Essential Hypertension |
3.0% |
| Hyperthyroidism |
2.9% |
| Hyperuricaemia |
2.9% |
| Polyuria |
2.7% |
| Pneumonia |
2.5% |
|
| Toxic Epidermal Necrolysis |
26.3% |
| Swollen Tongue |
14.0% |
| Stevens-johnson Syndrome |
8.8% |
| Nausea |
5.3% |
| Renal Function Test Abnormal |
5.3% |
| Bradyarrhythmia |
3.5% |
| Drug Interaction |
3.5% |
| Hypotension |
3.5% |
| Oedema Peripheral |
3.5% |
| Somnolence |
3.5% |
| Tachyarrhythmia |
3.5% |
| Therapeutic Agent Toxicity |
3.5% |
| White Blood Cell Count Increased |
3.5% |
| Bradycardia |
1.8% |
| Electrocardiogram St Segment Depression |
1.8% |
| Hypokalaemia |
1.8% |
| Sinus Bradycardia |
1.8% |
| Tachycardia |
1.8% |
| Torsade De Pointes |
1.8% |
| Unresponsive To Stimuli |
1.8% |
|
| Concomitant |
| Hypertension |
24.4% |
| Drug Use For Unknown Indication |
17.6% |
| Cardiac Failure |
7.7% |
| Atrial Fibrillation |
6.3% |
| Type 2 Diabetes Mellitus |
6.0% |
| Coronary Artery Disease |
4.5% |
| Diabetes Mellitus |
4.1% |
| Tachyarrhythmia |
3.9% |
| Pain |
3.5% |
| Prophylaxis Against Gastrointestinal Ulcer |
2.7% |
| Thrombosis Prophylaxis |
2.7% |
| Sleep Disorder |
2.3% |
| Pneumonia |
2.0% |
| Hypokalaemia |
1.9% |
| Hyperthyroidism |
1.8% |
| Hyperuricaemia |
1.8% |
| Urinary Tract Infection |
1.8% |
| Gouty Arthritis |
1.6% |
| Hypercholesterolaemia |
1.6% |
| Renal Failure Chronic |
1.6% |
|
| Drug Interaction |
15.3% |
| Renal Failure Acute |
10.8% |
| General Physical Health Deterioration |
6.3% |
| Vascular Pseudoaneurysm |
6.3% |
| Vomiting |
6.3% |
| Hypoglycaemia |
5.4% |
| Pancytopenia |
5.4% |
| Dyspnoea |
4.5% |
| Pericardial Haemorrhage |
4.5% |
| Renal Failure |
4.5% |
| Stevens-johnson Syndrome |
4.5% |
| Swollen Tongue |
3.6% |
| Transaminases Increased |
3.6% |
| Cardiac Failure |
2.7% |
| Cerebrovascular Accident |
2.7% |
| Faecaloma |
2.7% |
| Gastrointestinal Haemorrhage |
2.7% |
| Hypokalaemia |
2.7% |
| Renal Cyst |
2.7% |
| Respiratory Disorder |
2.7% |
|
| Interacting |
| Hypertension |
26.1% |
| Cardiac Failure |
8.7% |
| Cardiovascular Event Prophylaxis |
8.7% |
| Atrial Fibrillation |
6.5% |
| Hyperuricaemia |
6.5% |
| Acidosis |
4.3% |
| Anaemia |
4.3% |
| Helicobacter Gastritis |
4.3% |
| Hypercholesterolaemia |
4.3% |
| Hyperparathyroidism |
4.3% |
| Osteoarthritis |
4.3% |
| Rheumatoid Arthritis |
4.3% |
| Arrhythmia Prophylaxis |
2.2% |
| Asthma |
2.2% |
| Bronchitis |
2.2% |
| Coronary Artery Disease |
2.2% |
| Pyelonephritis |
2.2% |
| Type 2 Diabetes Mellitus |
2.2% |
|
| Nausea |
40.0% |
| Drug Interaction |
20.0% |
| Vomiting |
20.0% |
| White Blood Cell Count Increased |
20.0% |
|
